Novartis AG (0QLR)
LSE
Closed
Aug 21, 2026
Day's Range
124.0452 wk Range
96.06Overview - 0QLR - Novartis AG
Key Statistics
Valuation
Enterprise Value
154.02B
P/E (Trailing)
‪39.65‬
PEG Ratio
‪-2.28‬
Price / Sales (TTM)
‪5.49‬
Price / Book
‪5.07‬
EV / EBITDA
‪9.62‬
Profitability
Gross Margin
‪75.18%‬
Profit Margin
‪14.41%‬
Operating Margin
‪27.69%‬
Return on Assets
‪7.85%‬
Return on Equity
‪13.31%‬
Ownership
Shares Outstanding
1.90B
Float
1.97B
Held by Insiders
‪3.94%‬
Held by Institutions
‪36.07%‬
Price stats
Beta
‪0.48‬
50-Day Avg
‪124.66‬
200-Day Avg
‪118.03‬
Dividends
Payout Ratio
‪97.30%‬
Frequency
Annual
Market Cap - 0QLR - Novartis AG
Peers - 0QLR - Novartis AG
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on LSE.
- 0QLRLSENovartis AG291.74BMarket Cap+19.68%52-week change38.21P/E (Trailing)‪14.41%‬Profit Margin
- AZNLSEAstraZeneca PLC22.41TMarket Cap+29.32%52-week change28.74P/E (Trailing)‪17.18%‬Profit Margin
- GSKLSEGSK plc7.68TMarket Cap+23.40%52-week change16.26P/E (Trailing)‪14.52%‬Profit Margin
- 0QIULSENovo Nordisk A/S1.24TMarket Cap-23.24%52-week change20.09P/E (Trailing)‪33.39%‬Profit Margin
- 0QCVLSEAbbVie Inc.478.52BMarket Cap+21.83%52-week change54.73P/E (Trailing)‪15.50%‬Profit Margin
- 0QAHLSEMerck & Co., Inc.383.85BMarket Cap+44.02%52-week change63.23P/E (Trailing)‪5.33%‬Profit Margin
- 0K9ELSENovartis AG Sponsored ADR367.33BMarket Cap+20.90%52-week change0.15P/E (Trailing)‪22.50%‬Profit Margin
Profile Summary - 0QLR - Novartis AG
About
Novartis AG is a Swiss multinational pharmaceutical company headquartered in Basel, specializing in innovative medicines across multiple therapeutic areas including cardiovascular, immunology, neuroscience, oncology, and renal and metabolic diseases. The company operates through two primary divisions: Innovative…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
